Features Pharma and Self-Perception: Knights, Knaves or Pawns?

Pharma and Self-Perception: Knights, Knaves or Pawns?

Even the industry's sunniest personalities don't deny that pharma has an image problem among outside constituencies, with an unfortunately high percentage of observers believing the biz is first and foremost about profits. Sachin Jain dives deep on this and other perceptions—accurate and otherwise—about the industry and its marketing machinery

Features

Partner Forum: Social for HCPs—Is Now the Time?

The increasing use of social media to reach consumers in the healthcare arena raises questions: Is it time to leverage it for HCPs, and if so, what are the most viable platforms for pharma-HCP communications?

Features Private View: Elliott Smith

Private View: Elliott Smith

Features EHR Update: Record Correction

EHR Update: Record Correction

Of all the channels through which brands can connect with HCPs, electronic health records have long been considered the most stubbornly and frustratingly impenetrable. Might advances in analytics and cloud technology, among other recent innovations, help simplify the EHR equation? Sarah Mahoney investigates

Features Loyalty Programs: Beyond the Co-Pay Card

Loyalty Programs: Beyond the Co-Pay Card

In the past, when pharma companies talked about patient-loyalty programs, what they were really talking about were the financial incentives underpinning them. But in the wake of Novo Nordisk's successful support program for diabetics, Cornerstones4Care, such initiatives are finally set to evolve. James Chase reports on the shifting focus of patient support

Features FDA Policy: Is Off-Label on the Table?

FDA Policy: Is Off-Label on the Table?

In years past pharma marketers had to check themselves before conveying off-label product claims, even though those off-label uses had long since become standards of care. But in recent months the FDA has signaled a willingness to open the off-label information floodgates. Former FDA Associate Commissioner Peter Pitts explains exactly why this matters

Features 2015 Top 20 Companies: Shire

2015 Top 20 Companies: Shire

Features 2015 Top 20 Companies: Biogen

2015 Top 20 Companies: Biogen

Features 2015 Top 20 Companies: Otsuka

2015 Top 20 Companies: Otsuka

Features 2015 Top 20 Companies: Mylan

2015 Top 20 Companies: Mylan

Features 2015 Top 20 Companies: AbbVie

2015 Top 20 Companies: AbbVie

Features 2015 Top 20 Companies: Actavis

2015 Top 20 Companies: Actavis

Features 2015 Top 20 Companies: Sanofi

2015 Top 20 Companies: Sanofi

Features 2015 Top 20 Companies: Amgen

2015 Top 20 Companies: Amgen

Features 2015 Top 20 Companies: Teva

2015 Top 20 Companies: Teva

Features 2015 Top 20 Companies: Merck

2015 Top 20 Companies: Merck

Features 2015 Top 20 Companies: Roche

2015 Top 20 Companies: Roche

Features 2015 Top 20 Companies: Pfizer

2015 Top 20 Companies: Pfizer

Features 2015 Top 20 Companies: Novartis

2015 Top 20 Companies: Novartis

Features Pharma Report: A Sunny Day in Pharmaland

Pharma Report: A Sunny Day in Pharmaland

The year 2014 stunned even the sunniest of pharmaceutical optimists. Read our report

Features Ayman Chit, Senior Director, Sanofi Pasteur

Ayman Chit, Senior Director, Sanofi Pasteur

Session: Battle of the Big Idea

Features Headliner: Pfizer's mentoring maestro hones his craft

Headliner: Pfizer's mentoring maestro hones his craft

The Healthcare Businesswoman's Association 2015 Honorable Mentor has elevated mentoring to a prominent place.

Features Amanda Sheldon, Director, Digital Marketing and Communications, Medtronic Diabetes

Amanda Sheldon, Director, Digital Marketing and Communications, Medtronic Diabetes

Session: Inspiring the Future 40/ Intelligent Connections

Features Shwen Gwee, Associate Director, (Global) Digital Customer Engagement, Biogen

Shwen Gwee, Associate Director, (Global) Digital Customer Engagement, Biogen

Session: Inspiring the Future 40

Features Marc Sirockman, Executive Vice President and General Manager, Artcraft Health

Marc Sirockman, Executive Vice President and General Manager, Artcraft Health

Session: The patient view on transformation: empathy, education and empowerment

Features Melissa Mackey, Head, Social Media CoE, U.S. Digital Medicines, Novartis

Melissa Mackey, Head, Social Media CoE, U.S. Digital Medicines, Novartis

Session: Inspiring the Future 40

Features Charles "Chuck" Gershman, Founder, President and COO, Kuveda, Inc.

Charles "Chuck" Gershman, Founder, President and COO, Kuveda, Inc.

Session: Intelligent Connections

Features Jill McNair, Director of Education, Outreach and Community Support, CISCRP

Jill McNair, Director of Education, Outreach and Community Support, CISCRP

Session: The patient view on transformation: empathy, education and empowerment

Features Paul Magill, Senior Advisor, McKinsey & Company

Paul Magill, Senior Advisor, McKinsey & Company

Session: Battle of the Big Idea

Features Read the complete April 2015 Digital Edition

Read the complete April 2015 Digital Edition

Click the above link to access the Digital Edition of the April 2015 issue of MM&M, with all text, charts and pictures.

Features SkillSets: Omnicare Inc.

SkillSets: Omnicare Inc.

A monthly showcase of companies offering expertise, experience and services within specific areas of the industry. This month: Rare Diseases

Features Engaging HCPs: Rep and a Hard Place

Engaging HCPs: Rep and a Hard Place

Technology has, quite clearly, transformed the role of the sales rep. But at the same time, predictions that the rep would go the way of the dodo bird have themselves been proved false. James Chase surveys the rep's role in a changing media and sales environment

Features Headliner: Dexcom device executive presses connectivity

Headliner: Dexcom device executive presses connectivity

"Some people wake up in the middle of the night worrying about business," Kevin Sayer says. But when he wakes up he can't sleep because he's so excited!

Features Rare Diseases: Target Practice

Rare Diseases: Target Practice

The orphan-drug market was flying high before President Obama announced plans to devote $215 million to the funding of a Precision Medicine Initiative. Imagine the excitement among interested audiences now that those plans have picked up momentum. Frank Celia reports

Features DTC Report: DTC Unbound

DTC Report: DTC Unbound

DTC pharma advertising works—ask anyone. But over the years, its effectiveness has been blunted by FDA requirements that, marketers claim, befog rather than clarify. Larry Dobrow surveys the DTC landscape in the wake of the FDA's new—and some say revolutionary—guidance for communicating risk information in print ads

Features Drew Miller, Creative Director, frog design

Drew Miller, Creative Director, frog design

Session: Shifting Healthcare from Product to Experience

Features MarlaJan DeFusco BSN, RN, CPN, Lupus Health Activist, & Author, Luck Fupus Blog

MarlaJan DeFusco BSN, RN, CPN, Lupus Health Activist, & Author, Luck Fupus Blog

Session: The patient view on transformation: empathy, education and empowerment

Features Monique Levy, Vice President, Research, Manhattan Research

Monique Levy, Vice President, Research, Manhattan Research

Session: Pharma's Digital Disconnect

Features Dr. Navarra Rodriguez, Chief Medical Informatics Officer, AdvantageCare Physicians

Dr. Navarra Rodriguez, Chief Medical Informatics Officer, AdvantageCare Physicians

Session: The patient view on transformation: empathy, education and empowerment

Features DTC Report: Ten Best DTC Ads of 2014

DTC Report: Ten Best DTC Ads of 2014

Below, a review of last year's 10 best DTC ads, excerpted from MM&M's April cover story, "DTC Report: DTC Unbound," which will be viewable online on Wednesday, March 25. Mary Skoyles reports

Features Matt Brown, CEO, Guidemark Health

Matt Brown, CEO, Guidemark Health

Session: Inspiring the Future 40

Features Jack Barrette, CEO, WEGO Health

Jack Barrette, CEO, WEGO Health

Session: What is a business model and how do you sell it?

Features Lita Sands, Former Global Head, Digital Transformation, Novartis

Lita Sands, Former Global Head, Digital Transformation, Novartis

Session: The patient view on transformation: empathy, education and empowerment

Features Tom Kottler, CEO and Co-Founder of HealthPrize Technologies

Tom Kottler, CEO and Co-Founder of HealthPrize Technologies

Session: What is a business model and how do you sell it?

Features Larry Brooks, Director, Business Innovation: Digital Health at Boehringer Ingelheim

Larry Brooks, Director, Business Innovation: Digital Health at Boehringer Ingelheim

Session: What is a business model and how do you sell it?

Features Read the complete MM&M Digital Guide 2015

Read the complete MM&M Digital Guide 2015

Click the link below to access MM&M's Digital Guide 2015, with all text, charts and pictures.

Features Melissa Manice, CoheroHealth, CEO and Co-founder

Melissa Manice, CoheroHealth, CEO and Co-founder

Session: Battle of the Big Idea

Features Andy DiSimone, Director of Digital, StartUp Health

Andy DiSimone, Director of Digital, StartUp Health

Session: Battle of the Big Idea

Features Read the complete March 2015 Digital Edition

Read the complete March 2015 Digital Edition

Click the above link to access the Digital Edition of the March 2015 issue of MM&M, with all text, charts and pictures.

Features Mark Hadfield, CEO & Founder, HelloMD

Mark Hadfield, CEO & Founder, HelloMD

Session: Inter-generational Executive Summit Panel

Features Brandon Seeyle, Marketing Product Manager, Medivation

Brandon Seeyle, Marketing Product Manager, Medivation

Session: Intelligent Connections

Features

Companies at a Glance 2015

Features Digital Partners 2015

Digital Partners 2015

Features

Think Tank: There's Work to Do

Five digital pharma experts benchmark the industry's progress and project the next big digital trends

Features Consumers: Patients and Virtues

Consumers: Patients and Virtues

Consumers come with the same basic set of instructions as HCPs—find out what they need, then offer meaningful solutions. But be warned: Shiny objects may cause a temporary loss of vision

Features Healthcare Professionals: Chaos Breeds Opportunity

Healthcare Professionals: Chaos Breeds Opportunity

Increasingly pressed for time, the last thing physicians need is more engagement opportunities with pharma, right? Wrong. It's all about offering the right content in the right format at the right time

Features Overview: Can't, Won't, Don't Stop

Overview: Can't, Won't, Don't Stop

As pharma continues to scale the digital curve, James Chase's assessment of the landscape paints a familiar picture of progress and encouragement mixed with frustration and pain

Features Joe Shields, Global Director, Digital Strategy, AstraZeneca Pharmaceuticals

Joe Shields, Global Director, Digital Strategy, AstraZeneca Pharmaceuticals

Session: Battle of the Big Idea

Features Skill Sets: Cello Health Insight

Skill Sets: Cello Health Insight

A monthly showcase of companies offering expertise, experience and services within specific areas of the industry. In this edition: multichannel marketing

Features MAHF 2015: An Evening of Icons

MAHF 2015: An Evening of Icons

The industry celebrated its most precious asset—its people—at The Pierre in New York City on February 3 with a dinner honoring the two most recent inductees to the Medical Advertising Hall of Fame and the 2015 "Future Famers"

Features How to Win an MM&M Award: 2015

How to Win an MM&M Award: 2015

You have fewer than six weeks to enter the MM&M Awards. No problem. Follow our checklist of Do's and Don'ts and tune in to our webcast on March 24 for more tips.

Features

Partner Forum: Can evidence show POC the way?

EHRs can deliver evidence-based information about giving the right medicine to the right patient at the right time. How can industry craft point-of-care marketing that is both relevant and useful?

Features Marketing Research: Collaboration Proclamation

Marketing Research: Collaboration Proclamation

The combination of EHR, sensor and biomarker data is working to break down traditional barriers to collaboration among top-flight HEOR researchers

Features Multichannel Marketing: Multichannel Matures

Multichannel Marketing: Multichannel Matures

Most healthcare marketers understand the need for their programs to live in a range of channels. Now comes the hard part: Balancing their efforts across the multichannel spectrum. Michael Spitz offers some advice to marketers who get the "why" but need some help with the "how"

Features Mobile Marketing: It's Go Time

Mobile Marketing: It's Go Time

The sales reps are game, the HCPs are receptive and the mobile technology is ready. Rebecca Mayer Knutsen reports on the circumstances that have converged to provide pharma with its most promising mobile selling moment to date

Features Therapeutic Focus: Metabolic

Therapeutic Focus: Metabolic

Is this finally the year that anti-obesity drugs make the leap from niche curio to mainstream therapy? Frank Celia reports on the changing practitioner mind-set that could shift odds in favor of several new weight-loss options

Features Formulary Fireworks

Formulary Fireworks

In the wake of the high-profile showdown between Gilead and Express Scripts over the pricing of hepatitis-C drugs Sovaldi and Harvoni, the pharma/PBM balance of power may well have shifted—but not to the degree that many observers had predicted

Features Journal Ad Review: Back in the Mix

Journal Ad Review: Back in the Mix

A few years ago medical publishers were approaching a cliff and the choices were simple: Evolve the business or fall over the edge. By having learned to survive, some publishers are now ready to thrive

Features Dan Renick, Co-President and CCO, Precision for Medicine

Dan Renick, Co-President and CCO, Precision for Medicine

Session: Precision Medicine

Features Headliner: New Synta chief adds commercialization clout

Headliner: New Synta chief adds commercialization clout

Anne Whitaker, President and CEO, Synta Pharmaceuticals

Features Peter Frishauf, Director, Context Matters Inc.

Peter Frishauf, Director, Context Matters Inc.

Session: Battle of the Big Idea

Features Nirav "Rav" Sheth, Director of Market Development, Medical, MC10

Nirav "Rav" Sheth, Director of Market Development, Medical, MC10

Session: The wearable experience

Features Read the complete February 2015 Digital Edition

Read the complete February 2015 Digital Edition

Click the above link to access the Digital Edition of the February 2015 issue of MM&M, with all text, charts and pictures.

Features MM&M Awards—Fields of Gold

MM&M Awards—Fields of Gold

The MM&M Awards 2015 program is officially open for business

Features

Does account + creative ≠ agency?

Changing pharma demands and the ever-expanding skills of job seekers (tech, UX, search, mobile) have altered agency team structure. How must agency-client relations change to keep to the new model?

Features Nothing (Im)personal

Nothing (Im)personal

With unprecedented numbers of practices locking out sales reps, pharma companies are being forced to do a better job of engaging HCPs in other ways

Features Men of Agency

Men of Agency

Francis Gace and Dr. H. James Barnum took different paths to the top but each left a lasting mark on the advertising business. Barbara Peck celebrates the legacies of the two latest inductees to the Medical Advertising Hall of Fame

Features Hot Space

Hot Space

Our second annual survey of patients, physicians and payers reveals a significant degree of frustration—on every side—in an around the ever-booming specialty drug segment. Sarah Morgan interprets the results

Features David Weingard, Founder & CEO, Fit4D

David Weingard, Founder & CEO, Fit4D

Session: Intelligent Connections

Features Therapeutic Focus: Rare Diseases

Therapeutic Focus: Rare Diseases

The rare disease drug market is making history with its steady growth and burgeoning pipeline—and owing to continuing breakthroughs in gene therapy, the biggest advances are yet to come. Rebecca Mayer Knutsen reports on a sector that is thriving—and on the possibility that issues around pricing can slow its surge.

Features Mobile Marketing Report: On Hold

Mobile Marketing Report: On Hold

It's not as though pharma marketers didn't see mobile coming. For the past half decade, they've discussed its potential to transform behaviors and relationships within the healthcare ecosystem. Yet now that mobile has arrived, they find themselves torn between caution and exuberance. Larry Dobrow explains

Features Meg Columbia-Walsh, Partner, Global Lead of Digital Innovation and Marketing Excellence, Ernst & Young

Meg Columbia-Walsh, Partner, Global Lead of Digital Innovation and Marketing Excellence, Ernst & Young

Session: Inter-generational Executive Summit Panel

Features Josh Stein, CEO & Co-Founder, AdhereTech

Josh Stein, CEO & Co-Founder, AdhereTech

Session: Inter-generational Executive Summit Panel

Features Benjamin Wolin, CEO & Co-Founder, Everyday Health

Benjamin Wolin, CEO & Co-Founder, Everyday Health

Session: Inter-generational Executive Summit Panel

Features Ingo Elfering, Chief Information Officer, Indivior

Ingo Elfering, Chief Information Officer, Indivior

Session: Navigating Pharma Internal

Features Michele Polz, Head, Patient Insights, Global Commercial Strategy, Biogen

Michele Polz, Head, Patient Insights, Global Commercial Strategy, Biogen

Session: Rapid innovation and Big Pharma

Features Headliner: Scientist CEO sets sights on Sierra Leone

Headliner: Scientist CEO sets sights on Sierra Leone

Thomas Sack, President and CEO, MRIGlobal

The 2015 healthcare agency questionnaire, for firms hoping to be featured in the Top 100 Agencies issue, is live. Click here to be considered.

Email Newsletters